Search clinical trials for: Leukotriene Receptor Antagonist

Total 37607 results

Otsuka Pharmaceutical Development & Commercialization...

Withdrawn

Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder

Nervous System Diseases | Schizophrenia | Mental Disorder | Bipolar 1 Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials

Schizophrenia

France, South Africa, Canada, Russian Federation, Poland, Czech Republic, Hungary, Croatia, Netherlands, Romania, United Kingdom
University Hospitals Cleveland Medical Center
Bristol-Myers Squibb

Completed

Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder)

Attention Deficit Hyperactivity Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole

Schizophrenia

United States
Indiana University School of Medicine
Bristol-Myers Squibb

Completed

A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.

Asperger's Disorder | Pervasive Developmental Disorder

United States
University of North Carolina, Chapel Hill
Bristol-Myers Squibb

Completed

Study of Aripiprazole to Treat Children and Adolescents With Autism (PAIRS)

Autism Spectrum Disorder | Autistic Disorder | Asperger Syndrome

United States
Otsuka Pharmaceutical Co., Ltd.

Completed

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Bipolar I Disorder

Taiwan, Korea, Republic of, Japan, China
Otsuka Pharmaceutical Co., Ltd.

Completed

A Multicenter, Investigative Study of the Safety and Efficacy of Extended Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Bipolar I Disorder

Taiwan, Korea, Republic of, Japan, China
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type

Dementia, Alzheimer Type
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study of Aripiprazole in Subjects With Alcoholism

Alcoholism

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder | Psychotic Disorder | Body Weight Change

United States, Brazil, United Kingdom
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease

Parkinson's Disease | Psychoses

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Aripiprazole Oral Acceptability Trial

Schizophrenia

United States
The University of Texas Health Science Center at...
Bristol-Myers Squibb

Completed

Study Comparing Patients Taking Olanzapine and Patients Taking Aripiprazole on Learning of Vocational Skills

Schizoaffective Disorder | Schizophenia Disorder

United States
Juan A. Arnaiz

Unknown

ARIpiprazole in Anorexia NErvosa (ARIANE)

Anorexia Nervosa

Spain
University of Malaya

Completed

Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome

Schizophrenia

Malaysia
Pfizer

Completed

Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia

Schizophrenia

United States, India, Russian Federation, Ukraine
Louisiana State University Health Sciences Center...
SAM Technology & The San Francisco Brain Research Institute

Terminated

Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI)

Schizophrenia | Schizoaffective Disorder

United States
Northwell Health
Bristol-Myers Squibb

Terminated

Aripiprazole Treatment of the Prodrome

Prodromal Schizophrenia | Prodromal Psychosis

United States
State University of New York - Upstate Medical...
Bristol-Myers Squibb

Completed

Aripiprazole as Augmentation for TRD

Depression

United States
Genovate Biotechnology Co., Ltd.,

Unknown

Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia

Dyslipidemia | Weight Gain | Hyperprolactinemia
Otsuka Canada Pharmaceutical Inc.
Lundbeck Canada Inc.

Recruiting

Aripiprazole Once-Monthly in Hospitalized Patients (INITIATE) (INITIATE)

Schizophrenia | Schizo Affective Disorder | Bipolar I Disorder

Canada
Otsuka Pharmaceutical Co., Ltd.

Completed

Post-Marketing Surveillance Study of Aripiprazole in Patients With Autism

Autism

Japan
Otsuka Pharmaceutical Development & Commercialization...

Terminated

A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®

Schizophrenia

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients

Schizophrenia

United States
Otsuka Beijing Research Institute

Completed

Aripiprazole IM Depot for Chinese Patients With Schizophrenia

Schizophrenia

China
Otsuka Beijing Research Institute

Completed

PK Study of Aripiprazole IM Depot for Chinese Patients With Schizophrenia

Schizophrenia

China
Fundación Marques de Valdecilla
Centro de Investigación Biomédica en Red de Salud Mental; Instituto de Investigación...

Unknown

Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up (PAFIP3_nc3Y)

Psychotic Disorders | Schizophrenia | Psychosis

Spain
Alkermes, Inc.

Completed

An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia

Schizophrenia

United States
Medical University of South Carolina
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Aripiprazole Effects on Alcohol Drinking and Craving

Alcohol Dependence

United States
University Hospitals Cleveland Medical Center
Bristol-Myers Squibb

Completed

Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar Disorder

Bipolar Disorder

United States
Indiana University School of Medicine

Completed

A Prospective Open-label Study of Aripiprazole in Fragile X Syndrome

Fragile X Syndrome

United States
National Institute on Drug Abuse (NIDA)

Unknown

Assessment of Interactions Between Methamphetamine and Aripiprazole - 1

Amphetamine-Related Disorders

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka Pharmaceutical Co., Ltd.

Completed

Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute Schizophrenia

Schizophrenia
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S; Otsuka America Pharmaceutical

Completed

Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia

Schizophrenia

United States, Croatia, Latvia
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

Tic Disorder | Tourette's Disorder

United States, Germany, Spain, Mexico, Romania, Canada, Hungary, Italy, Sweden
University Hospitals Cleveland Medical Center
Bristol-Myers Squibb

Completed

Study of Aripiprazole (Abilify) in Children With Symptoms of Mania

Bipolar Disorder

United States
Anne Katrine Pagsberg
Albert Einstein College of Medicine; The Research Council for Health and Disease... and other collaborators

Unknown

Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA)

Psychosis

Denmark
Otsuka Pharmaceutical Development & Commercialization...

Completed

An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia

Schizophrenia

United States
Yoo-Sook Joung
Korea Otsuka International Asia Arab

Unknown

Study to Evaluate the Efficacy and Safety of Aripiprazole

Autism

Korea, Republic of, Philippines, Thailand
Otsuka Pharmaceutical Co., Ltd.

Completed

Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism-

Schizophrenia

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
University of North Carolina, Chapel Hill
Bristol-Myers Squibb

Completed

Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine

Mood Disorders | Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)

Autistic Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)

Behavioral Symptoms | Autistic Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)

Behavioral Symptoms | Autistic Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode

Bipolar Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder

Bipolar I Disorder

United States, Argentina
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia

Schizophrenia

United States

Search clinical trials for: Leukotriene Receptor Antagonist

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations